Dr. Balis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
Children's Hospital Of Philadelphia - Hem/Onc
Philadelphia, PA 19104Phone+1 215-426-5414
Education & Training
- National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1982 - 1985
- University of WashingtonFellowship, Pediatric Hematology/Oncology, 1978 - 1981
- Vanderbilt University Medical CenterResidency, Pediatrics, 1975 - 1978
- Vanderbilt University School of MedicineClass of 1975
Certifications & Licensure
- PA State Medical License 2009 - 2024
- MD State Medical License 1982 - 2016
- WA State Medical License 1978 - 1982
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma Start of enrollment: 2000 Mar 01
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
- Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
- Join now to see all
Publications & Presentations
PubMed
- Atypical presentations of RECQL4-related syndromes.Liron D Grossman, Sarah Baldino, Kristin Zelley, Frank Balis, Rochelle Bagatell
Pediatric Blood & Cancer. 2024-12-01 - Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials.Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane, Sapna Oberoi, Frank M Balis
Cancer. 2024-11-15 - Population modeling analyses of crizotinib in pediatric patients with ALK-positive advanced cancers.Li Jerry, Lin Swan, Nickens Dana, Frank M Balis, Emily Greengard
Pediatric Blood & Cancer. 2024-09-01
Press Mentions
- A Pharmacologically-Based Approach to High Dose Methotrexate Administration to Investigate Nephrotoxicity and Acute Kidney Injury Biomarkers in Children and Adolescents with Newly Diagnosed OsteosarcomaMarch 7th, 2021
Grant Support
- Fluorescent Pteridine Nucleoside AnalogsDivision Of Clinical Sciences - Nci2009
- Anticancer Drug Development For Childhood CancersDivision Of Clinical Sciences - Nci2009
- Clinical Pharmacology Of Anticancer DrugsDivision Of Basic Sciences - Nci2009
- Clinical Pharmacology Of Anticancer DrugsNational Cancer Institute2008
- Anticancer Drug Development For Childhood CancersNational Cancer Institute2008
- Drug Development And Clinical Pharmacology Of Anticancer Drugs For Childhood CanNational Cancer Institute2007
- Drug Development And Clinical Pharmacology Of AnticancerDivision Of Clinical Sciences - Nci2001–2006
- Drug Development &Clinical Pharma. Of Anticancer DrugsDivision Of Clinical Sciences - Nci2004
- Drug Development &Clinical Pharmacology Of Anticancer DDivision Of Clinical Sciences - Nci2000
- Drug Development And Clinical Pharmacology Of Anticancer And Antiretroviral DrugsDivision Of Clinical Sciences - Nci1999
- Clinical Pharmacology Of Anticancer And Antiretroviral DrugsDivision Of Clinical Sciences - Nci1996–1998
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: